Pleased to meet you, we are Galapagos, a dynamic growing Biotech company with offices across Europe and in US, headquartered in Mechelen, Belgium.
We are in the business of changing lives. Focusing on high unmet medical needs, we synergize compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class small molecules, CAR-T therapies and biologics in oncology and immunology. With capabilities from lab to patient, including Decentralized Manufacturing Unit(s) of CAR-T, we are committed to challenging the status quo and delivering results for our patients, employees and shareholders.
We pioneer for patients. We need thought leaders and rapid thinkers, entrepreneurs in spirit and status quo-fighters. Collaborative innovators and perseverant idealists. We need the best-in-class. In other words, we need you : The ‘make-it-happener’.
We are expanding our US footprint to set-up our decentralized CAR-T
network and further build our research capabilities in the US.
We are currently looking for a Head of ADME/DMPK - Mechelen, BE
Scope of the role
You will lead and manage the DMPK department and ensure that support the small molecule and antibody drug discovery projects with ADME/PK data all the way to human PK predictions. You will also contribute to the transition of new drug candidates from discovery to development and throughout development to MAA/NDA. You are responsible for the design of the scientific and organizational strategy, focused on DMPK/ADME, to develop novel competitive therapeutic drugs. You will lead the implementation of this strategy within your own team. As a leader of the ADME/DMPK Team, you will ensure teamwork with a special emphasis on high quality of data delivered in the best timelines. The communication between the DMPK/ADME department and other Discovery and Development teams should be handled with professionalism.
Your role
